Regulatory

RSS

Lidocaine nasal drops shown effective for fast migraine pain relief

Aug. 9, 1996

Actiq to undergo phase III clinical trials

Aug. 9, 1996

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

Leiras claims oral delivery system for oxybutynin chloride

July 26, 1996

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

Pharmacia & Upjohn introduces new dosage strength for Fragmin

July 26, 1996

SR-140333 claimed as a cardioregulatory drug

July 26, 1996

BES and BENSPM claimed as vascular proliferative disorders treatment

July 26, 1996

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996